This SuperSeries is composed of the SubSeries listed below.
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
Specimen part, Disease stage
View SamplesValidation dataset of 298 ER-positive patients treated with tamoxifen for 5 years.
No associated publication
Specimen part, Subject
View SamplesPURPOSE: To develop a predictive test for response and survival following neoadjuvant taxane-anthracycline chemotherapy for HER2-negative invasive breast cancer.
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
Specimen part, Disease stage
View SamplesPURPOSE: To develop an index capable of detecting and quantifying the extent of liver RNA contamination in liver biopsies of metastatic breast cancer
No associated publication
Specimen part
View SamplesPURPOSE: To develop a predictive test for response and survival following neoadjuvant taxane-anthracycline chemotherapy for HER2-negative invasive breast cancer.
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
Specimen part, Disease stage
View SamplesTime series of eleven breast cancer samples subjected to different cold ischemic stress of up to 3 hr post tumor excision.
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers.
Subject
View SamplesComparison of concordance in single and multi-gene genomic indices from data generated by two different laboratories (MD Anderson Cancer Center (MDA) and Jules Bordet Institute (JBI)) and on two different Affymetrix platforms (U113A and U133_Plus2).
Genomic index of sensitivity to endocrine therapy for breast cancer.
Specimen part, Subject
View SamplesMolecular and genomic analysis of microscopic quantities of tumor from formalin-fixed and paraffin-embedded (FFPE) biopsies has many unique challenges. Here we evaluated the feasibility of obtaining transcriptome-wide RNA expression to measure prognostic classifiers from diagnostic prostate needle core biopsies.
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.
Specimen part, Subject
View SamplesTo test the hypothesis that a genomic classifier (GC) would predict biochemical failure (BF) and distant metastasis (DM) in men receiving radiation therapy (RT) after radical prostatectomy (RP).
The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer.
Age
View SamplesNormal and diseased human tissues were profiled for gene expression using the Affymetrix U133 plus 2.0 array
No associated publication
Sex
View Samples